Global Oral Vaccines Market By type (Rotavirus Vaccine, Cholera Vaccineand Polio Vaccine), By Application (Infant, Childrenand Adults), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 134591
- 09-Dec
- PDF/PPT/Word
-
Report Details
The report on Oral Vaccines Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global oral vaccines market is segmented on the basis of Type, Application and geography.
The global Oral Vaccines market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.
Oral Vaccines Market Scope:
By type, the market is segmented into Rotavirus Vaccine, Cholera Vaccineand Polio Vaccine. By Application, the market is divided into Infant, Childrenand Adults. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include GlaxoSmithKline, PaxVax, Merial, Merck, Sanofi, Crucell, Quimica Suiza, Immunitor, Hualan Biological Engineering, Serum Institute of India, BB-NCIPDand Vaxart.
Key Market Segments
Type
Rotavirus Vaccine
Cholera Vaccine
Polio VaccineApplication
Infant
Children
AdultsKey Market Players included in the report:
GlaxoSmithKline
PaxVax
Merial
Merck
Sanofi
Crucell
Quimica Suiza
Immunitor
Hualan Biological Engineering
Serum Institute of India
BB-NCIPD
VaxartReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Oral Vaccines Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Oral Vaccines Market, high-growth regions, and market drivers, restraints and also market chances.
The analysis covers Oral Vaccines Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Oral Vaccines Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Oral Vaccines Market together side their company profiles, SWOT analysis, latest advancements and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
To know the Oral Vaccines Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Oral Vaccines sub-markets, depending on key regions (various vital states).
To analyze Oral Vaccines Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Oral Vaccines Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
Primary worldwide Oral Vaccines Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market. -
Table Of Content
1. Oral Vaccines Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope
2. Executive Summary
2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players
3. Global Oral Vaccines Market Overview
3.1. Oral Vaccines Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges
3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map
4. Global Oral Vaccines Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
4.1. Global Oral Vaccines Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Rotavirus Vaccine
4.4. Cholera Vaccine
4.5. Polio Vaccine
5. Global Oral Vaccines Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Oral Vaccines Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Infant
5.4. Children
5.5. Adults
6. Global Oral Vaccines Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Oral Vaccines Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico
6.2. Europe
6.2.1. Europe Oral Vaccines Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. Asia-Pacific Oral Vaccines Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia
6.4. Latin America
6.4.1. Latin America Oral Vaccines Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Middle East and Africa Oral Vaccines Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Oral Vaccines Market Competitive Landscape, Market Share Analysis, and Company Profiles
7.1. Market Share Analysis
7.2. Company Profiles
7.3. GlaxoSmithKline
7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments
7.4. PaxVax
7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments
7.5. Merial
7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments
7.6. Merck
7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments
7.7. Sanofi
7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments
7.8. Crucell
7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments
7.9. Quimica Suiza
7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments
7.10. Immunitor
7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments
7.11. Hualan Biological Engineering
7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments
7.12. Serum Institute of India
7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments
7.13. BB-NCIPD
7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments
7.14. Vaxart
7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments
8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
